Sysmex and bioMérieux Form a Global Partnership for Urinary Screening in Microbiology
05 Jul 2007 -
Sysmex Corporation and bioMérieux have signed an agreement today by which bioMérieux will become Sysmex's global partner for distributing its UF-1000i urinalysis system in microbiology laboratories. According to the companies, this synergistic partnership between two major players in the in vitro diagnostic market brings together Sysmex's recognized expertise in diagnostic analyzers and bioMérieux's leadership position in microbiology.
Current urinary screening methods, mainly based on microscope cell numeration, are still very manual, time-consuming and the source of errors. Sysmex has developed the fluorescence flow cytometry UF-1000i urinalysis system, a highly standardized and automated solution. bioMérieux will provide its extensive customer base with this new technology and leverage its expertise and reputation in microbiology to expand the market. Commercialization by bioMérieux will start in Europe in September 2007 and be followed by the U.S. and other countries at the beginning of 2008.